Rafael Amado - Insider Trading & Ownership

Entity
Individual
Location
210 East Grand Ave, South San Francisco, CA
Summary
The estimated net worth of Rafael Amado is at least $6.1M dollars as of August 14, 2024. Rafael Amado is the EVP of R&D of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $5.27M. Rafael Amado is the President, Head of Global Oncology Research and Development of Zai Lab Ltd and owns shares of Zai Lab Ltd (ZLAB) stock worth about $592K. Rafael Amado is the Director of Poseida Therapeutics, Inc. and owns shares of Poseida Therapeutics, Inc. (PSTX) stock worth about $243K.
All Insider Reports
All Insider Reports

Ownership of Rafael Amado

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALLO Allogene Therapeutics, Inc. EVP of R&D $5.27M Oct 7, 2022
ZLAB Zai Lab Ltd President, Head of Global Oncology Research and Development $592K -$638K -51.9% Aug 12, 2024
PSTX Poseida Therapeutics, Inc. Director $243K Jun 17, 2024

Insider Transactions Reported by Rafael Amado:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.